Phase 1 Neoplasms, Prostate Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

Neoplasms, Prostate

GlaxoSmithKline54 enrolled6 locationsNCT07332455

Recruiting

Phase 1Phase 2

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

Neoplasms, Prostate

GlaxoSmithKline85 enrolled15 locationsNCT06990880